Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Euro Falls Below Parity Vs U.S. Dollar For The First Time Since December 2002

News

Euro Falls Below Parity Vs U.S. Dollar For The First Time Since December 2002

-Reuters

byBenzinga Newsdesk

July 13, 2022

1 minute read

-Reuters

Oil At 6-Month High As Alleged Israel Airstrike On Damascus Fuels Concerns Over Wider Middle-East Conflict

By Neil Dennis

April 1, 3:24 PM

Israel kills top IRGC commander in attack on Iranian consulate in Damascus, escalating conflict with Hamas. Oil prices hit 6-month high.

USO

Operational Wins For General Electric: Analyst Sees Potential Upside From Vernova Spin-Off And Aerospace Growth

By Lekha Gupta

January 23, 2:22 PM

BofA Securities analyst Andrew Obin optimistic about GE's Q4 FY23 earnings and says spin-off of Vernova can lead to a re-rating in the near future.

News

Elon Musk Says Reports Of Him Meeting With Top U.S. Officials On EVs Is ‘True’

By Benzinga Newsdesk

January 27, 3:11 PM

https://twitter.com/elonmusk/status/1619049025357090816?s=20&t=gVewMYnmfvz44PG55nvV0A

INmune Bio Inc. Presents Data On INB03’s Role As An Immune Check Point Modulator In The Treatment Of High-Risk Breast Cancer At AACR 2024

By Benzinga Newsdesk

April 8, 8:16 AM

Novel Immunotherapy Approach Targets Soluble Tumor Necrosis Factor to Overcome Resistance and Enhance Therapeutic Outcome in High-Risk Breast CancerBoca Raton, Florida, April 08, 2024 (GLOBE NEWSWIRE) -- INmune

INMB

Euro Falls Below Parity Vs U.S. Dollar For The First Time Since December 2002

Related Posts

Oil At 6-Month High As Alleged Israel Airstrike On Damascus Fuels Concerns Over Wider Middle-East Conflict

Operational Wins For General Electric: Analyst Sees Potential Upside From Vernova Spin-Off And Aerospace Growth

Elon Musk Says Reports Of Him Meeting With Top U.S. Officials On EVs Is ‘True’

INmune Bio Inc. Presents Data On INB03’s Role As An Immune Check Point Modulator In The Treatment Of High-Risk Breast Cancer At AACR 2024